Page 12 - Pnt O News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pnt o. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pnt O Today - Breaking & Trending Today

MetLife Investment Management LLC Acquires 5,454 Shares of POINT Biopharma Global Inc. (NASDAQ:PNT)

MetLife Investment Management LLC grew its holdings in shares of POINT Biopharma Global Inc. (NASDAQ:PNT – Get Rating) by 13.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 46,389 shares of the company’s stock after purchasing an additional 5,454 shares during the period. MetLife Investment Management LLC’s […] ....

Zurcher Kantonalbank Zurich Cantonalbank , Raymond James , Biopharma Global Inc , Metlife Investment Management , Psagot Value Holdings Ltd , Capital Management , Biopharma Global Company Profile , Principal Financial Group Inc , Get Rating , Life Investment Management , Value Holdings , Kantonalbank Zurich Cantonalbank , Financial Group , Global Stock , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Oppenheimer Research Analysts Decrease Earnings Estimates for POINT Biopharma Global Inc. (NASDAQ:PNT)

POINT Biopharma Global Inc. (NASDAQ:PNT – Get Rating) – Investment analysts at Oppenheimer cut their FY2027 earnings per share (EPS) estimates for POINT Biopharma Global in a report issued on Monday, March 27th. Oppenheimer analyst J. Jones now forecasts that the company will post earnings per share of $0.21 for the year, down from their […] ....

Raymond James , Zurcher Kantonalbank Zurich Cantonalbank , Principal Financial Group Inc , Biopharma Global Company Profile , Point Biopharma Global Inc , Biopharma Global Inc , Psagot Value Holdings Ltd , Capital Management , Get Rating , Value Holdings , Kantonalbank Zurich Cantonalbank , Financial Group , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt , Earnings Estimates , Oppenheimer Holdings Inc ,

POINT Biopharma Global (NASDAQ:PNT) Announces Quarterly Earnings Results

POINT Biopharma Global (NASDAQ:PNT – Get Rating) issued its quarterly earnings results on Monday. The company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.26) by $1.79, MarketWatch Earnings reports. The business had revenue of $226.58 million during the quarter, compared to analyst estimates of $260.00 million. POINT Biopharma […] ....

Raymond James , Biopharma Global Inc , Capital Management , Biopharma Global Company Profile , Virtu Financial , Principal Financial Group Inc , Get Rating , Marketwatch Earnings , Global Stock Down , Financial Group , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

POINT Biopharma Global (NASDAQ:PNT) Posts Quarterly Earnings Results, Beats Expectations By $1.79 EPS

POINT Biopharma Global (NASDAQ:PNT – Get Rating) announced its earnings results on Monday. The company reported $1.53 earnings per share for the quarter, topping the consensus estimate of ($0.26) by $1.79, MarketWatch Earnings reports. The business had revenue of $226.58 million for the quarter, compared to analysts’ expectations of $260.00 million. POINT Biopharma Global Stock […] ....

United States , Raymond James , Biopharma Global Inc , E Fund Management Co , Fund Management Co , Shay Capital , Citigroup Inc , Delphia United States Inc , Get Rating , Marketwatch Earnings , Fund Management , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

POINT Biopharma Global (NASDAQ:PNT) Releases Earnings Results, Beats Estimates By $1.79 EPS

POINT Biopharma Global (NASDAQ:PNT – Get Rating) announced its earnings results on Monday. The company reported $1.53 EPS for the quarter, topping analysts’ consensus estimates of ($0.26) by $1.79, MarketWatch Earnings reports. The company had revenue of $226.58 million during the quarter, compared to analysts’ expectations of $260.00 million. POINT Biopharma Global Stock Performance POINT […] ....

Raymond James , Principal Financial Group Inc , Capital Management , Biopharma Global Inc , Virtu Financial , Biopharma Global Company Profile , Get Rating , Marketwatch Earnings , Global Stock , Financial Group , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,